Camp4 Therapeutics's three largest insider shareholders as of June 18, 2026 are Sciences Gp, Llc Enavate (TenPercentOwner, 3.79Mn shares), Partners Vi, Llc 5Am (TenPercentOwner, 2.94Mn shares), Andrew J. Schwab (Director, 2.94Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Richard A Young | - | 170,010 | 0 | 11 Sep, 2025 |
| Amir Nashat | - | 0 | 197,661 | 11 Sep, 2025 |
| Andrew J. Schwab | - | 0 | 2,941,176 | 15 Sep, 2025 |
| Equity Partners Bio I, L.L.C. Ah | - | 0 | 2,125,339 | 17 Oct, 2024 |
| Management Co. Vii, L.L.C. Polaris | - | 0 | 197,661 | 11 Sep, 2025 |
| Partners Vi, Llc 5Am | - | 0 | 2,941,176 | 15 Sep, 2025 |
| Ventures Ii Gp, Llc Northpond | - | 0 | 2,238,244 | 17 Oct, 2024 |
| Yuri Maricich | Chief Medical Officer | 6,060 | 0 | 11 Sep, 2025 |
| Josh Mandel-Brehm | Chief Executive Officer | 278,417 | 0 | 11 Sep, 2025 |
| Sciences Gp, Llc Enavate | - | 0 | 3,785,802 | 17 Oct, 2024 |
| Kelly Gold | Chief Financial Officer | 67,877 | 0 | 11 Sep, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 01 Apr, 2026 | Kelly Gold | Stock Option (Right to Buy) | A | 215,000 | $0.00 | 215,000 | D | A |
| 01 Apr, 2026 | Yuri Maricich | Stock Option (Right to Buy) | A | 215,000 | $0.00 | 215,000 | D | A |
| 01 Apr, 2026 | Daniel Tardiff | Stock Option (Right to Buy) | A | 170,000 | $0.00 | 170,000 | D | A |
| 01 Apr, 2026 | Josh Mandel-Brehm | Stock Option (Right to Buy) | A | 580,000 | $0.00 | 580,000 | D | A |
| 01 Apr, 2026 | Michael F Maclean | Stock Option (Right to Buy) | A | 56,000 | $0.00 | 56,000 | D | A |
| 01 Apr, 2026 | Kelly Gold | Stock Option (Right to Buy) | A | 215,000 | $0.00 | 215,000 | D | A |
| 01 Apr, 2026 | Daniel Tardiff | Stock Option (Right to Buy) | A | 170,000 | $0.00 | 170,000 | D | A |
| 11 Dec, 2025 | Kelly Gold | Stock Option (Right to Buy) | A | 190,000 | $0.00 | 190,000 | D | A |
| 11 Dec, 2025 | Yuri Maricich | Stock Option (Right to Buy) | A | 190,000 | $0.00 | 190,000 | D | A |
| 11 Dec, 2025 | Josh Mandel-Brehm | Stock Option (Right to Buy) | A | 425,000 | $0.00 | 425,000 | D | A |
| 11 Dec, 2025 | Daniel Tardiff | Stock Option (Right to Buy) | A | 145,500 | $0.00 | 145,500 | D | A |
| 11 Dec, 2025 | Kelly Gold | Stock Option (Right to Buy) | A | 190,000 | $0.00 | 190,000 | D | A |
| 11 Dec, 2025 | Daniel Tardiff | Stock Option (Right to Buy) | A | 145,500 | $0.00 | 145,500 | D | A |
| 11 Sep, 2025 | Partners Vi, Llc 5Am | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | P |
| 11 Sep, 2025 | Andrew J. Schwab | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | A |
| 11 Sep, 2025 | Partners Vi, Llc 5am | Common Stock | A | 2,941,176 | $1.53 | 2,941,176 | I | P |
| 11 Sep, 2025 | Management Co. Vii, L.L.C. Polaris | Common Stock | A | 1,221,721 | $1.53 | 2,825,500 | I | P |
| 11 Sep, 2025 | Richard A Young | Common Stock | A | 15,151 | $1.65 | 170,010 | D | P |
| 11 Sep, 2025 | Kelly Gold | Common Stock | A | 6,060 | $1.65 | 67,877 | D | P |
| 11 Sep, 2025 | Richard A Young | Common Stock | A | 15,151 | $1.65 | 170,010 | D | P |